Similar results were obtained with Toll-like receptor 4 (TLR4) and ERK inhibitors.<h4>Conclusions</h4>This pilot study demonstrates that METRNL is a novel potential biomarker for sepsis with diagnostic capability comparable to that of PCT. Here, METRNL is linked to Sepsis.